Re-exposure causing rapid onset of vancomycin induced thrombocytopenia

Vancomycin is used for the treatment of gram-positive infections. The increasing prevalence of methicillin-resistant Staphylococcus aureus since the 1980 s has led to a significant increase in the clinical utility of vancomycin in the United States. The diagnosis of vancomycin induced thrombocytopen...

Full description

Saved in:
Bibliographic Details
Published inIDCases Vol. 27; p. e01398
Main Authors Boodhai, Brent, Maharaj, Aarti, Rodriguez, Carmina Aybar, Lin, Yu Shia
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.01.2022
Elsevier
Subjects
Case Report
Drug rash
Rapid onset
Re-exposure
Thrombocytopenia
Vancomycin
Vancomycin induced thrombocytopenia
Thrombocytopenia
Vancomycin induced thrombocytopenia
Drug rash
Vancomycin
Re-exposure
Rapid onset
Online AccessGet full text

Cover

More Information
Summary:Vancomycin is used for the treatment of gram-positive infections. The increasing prevalence of methicillin-resistant Staphylococcus aureus since the 1980 s has led to a significant increase in the clinical utility of vancomycin in the United States. The diagnosis of vancomycin induced thrombocytopenia (VIT) poses a challenge since it requires the exclusion of other etiologies of thrombocytopenia, such as infectious or immunologic diseases and alternative drugs. Physicians should be aware that VIT is a rare but important complication of IV vancomycin therapy and failure to recognize this diagnosis may lead to a delay in discontinuation of vancomycin and serious complications
ISSN:2214-2509
2214-2509
DOI:10.1016/j.idcr.2022.e01398